CDC: 2018 to 2021 Saw Increase in Drug Overdose Deaths Involving Xylazine
FRIDAY, June 30, 2023 (HealthDay News) — From 2018 to 2021, there was an increase in the age-adjusted rate of drug overdose deaths involving xylazine, from 0.03 to 1.06 per 100,000 standard population, according to a June Vital Statistics Rapid Rele…
Learn More‘Como si ni estuviera ahí’: los niños con discapacidad son discriminados en la atención de la salud
JUEVES, 29 de junio de 2023 (HealthDay News) — Los niños con discapacidades sufren discriminación en los ambientes de la atención de la salud, en detrimento de su salud, según sus padres. Treinta entrevistas a profundidad con padres de hijos con disc…
Learn MoreSuicide Attempts, Suicide Mortality Up for Transgender Individuals
FRIDAY, June 30, 2023 (HealthDay News) — Transgender individuals have increased rates of suicide attempts and suicide mortality, according to a study published in the June 27 issue of the Journal of the American Medical Association.Annette Erlangsen,…
Learn MoreOne in Four Patients Die Within One Year of First Heart Failure Hospitalization
FRIDAY, June 30, 2023 (HealthDay News) — Globally, one in four heart failure patients die within the first year of their first heart failure-related hospitalization, according to a study published online June 21 in JACC: Heart Failure.Biykem Bozkurt,…
Learn MoreOverweight Tied to Better Head, Neck Cancer Outcomes After Chemoradiotherapy
FRIDAY, June 30, 2023 (HealthDay News) — Overweight body mass index (BMI) is associated with favorable outcomes in patients with nonmetastatic head and neck cancer undergoing chemoradiotherapy, according to a study published online June 27 in JAMA Ne…
Learn MoreBulevirtide Linked to Decline in Hepatitis D Virus RNA Levels
FRIDAY, June 30, 2023 (HealthDay News) — For patients with hepatitis D virus (HDV), bulevirtide is associated with a reduction in HDV RNA levels and alanine aminotransferase (ALT) levels, according to a study published online June 22 in the New Engla…
Learn MorePegozafermin Leads to Improvements in Fibrosis in NASH
FRIDAY, June 30, 2023 (HealthDay News) — For patients with biopsy-confirmed nonalcoholic steatohepatitis (NASH) and stage F2 or F3 fibrosis, treatment with pegozafermin leads to improvements in fibrosis, according to a study published online June 24 …
Learn MoreMeds Rarely Initiated After Discharge for Alcohol Use Disorder
FRIDAY, June 30, 2023 (HealthDay News) — Patients hospitalized for alcohol use disorder (AUD) rarely initiate medications for AUD (MAUD) after discharge, according to a research letter published online June 27 in the Annals of Internal Medicine.Eden …
Learn MoreSoaring Misuse of Horse Tranquilizer Xylazine Is Worsening Opioid Crisis
FRIDAY, June 30, 2023 (HealthDay News) — Drug overdose deaths involving a powerful horse tranquilizer called xylazine have skyrocketed in the United States, rising 35-fold in just a handful of years, federal health researchers say.The number of xylaz…
Learn MoreAir Polluted With Wildfire Smoke Can Harm Animals, Too
FRIDAY, June 30, 2023 (HealthDay News) — The Canadian wildfires that are burning out of control have brought hazy skies and polluted air to parts of the United States unprepared for it — and that’s affecting not just the people, but their pets and …
Learn More